BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

Gliosarcoma Reports From BioPortfolio:

Market Research Reports / Management Reports / Research Reports

Results from other life science and pharmaceutical sites:

MCW Office of Technology Development :: Therapeutics
23 Feb 2009 ... Find Research by ... Dennis Devitt, MSc, MBA Director Marketing & Licensing Office of Technology Development 414-456-8152 ddevitt@mcw.edu ...
http://www.mcw.edu/TreatmentofTumorsbytheInhibitionofAngioge...

Interstitial chemotherapy with biodegradable BCNU (Gliadel ...
Further research work also showed that the systemic and intrathecal .... the standard dose to be used in the phase III clinical trials and marketing. .... At
the last report, 33 patients were enrolled, with a median follow-up of 8.1
months. ..... Interstitial chemotherapy of the 9L gliosarcoma: controlled
release ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376068/...

The Scripps Research Institute - Cancer
Furthermore, the scientists report the compound can block the growth of tumors in ... Using a syngenic rat 9L gliosarcoma model, TSRI Professor Martin
Friedlander, .... and a number of successful drugs on the market for lung,
breast, ...
http://www.scripps.edu/philanthropy/cancer.html...

In Vivo Cellular Imaging for Translational Medical Research
This study provides the first report on the quantification of the label being .... Gliosarcoma 9L cell line was also shown to initiate an immunogenic ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=27...

Ateam of scientists from BNL and Less than three months after the ...
1 Sep 2000 ... brain of a laboratory rat with a gliosarcoma tumor (oval-shaped area at top center of each image). .... communication to share BNL's research and operations
with the community. .... The fiscal year 2000 report will be submitted to DOE in
October. The .... prototyping, marketing plans, feasibil- ...
http://www.bnl.gov/bnlweb/pubaf/bulletin/2000/bb090100.pdf...

Bear Stearns VION PHARMA
rights that preclude the Company from marketing its products, the possibility that third parties will ..... GBM/gliosarcoma. – Stratum II: recurrent/
progressive GBM. – Stratum III: ... Industry research reports and company
filings ...
http://www.vionpharm.com/pdf/BearStearns06.pdf...

Shark cartilage
Research on AE-941 has rejuvenated interest in shark cartilage for ... sulfate origin of products available on the Japanese market were determined (30). ...
There is a case report of a nine year-old brain tumor patient whose parents
...... of the rat 9L gliosarcoma: evaluation of the effects of shark cartilage.
...
http://www.naturalstandard.com/monographs/herbssupplements/s...

NovaRx Corporation Release: Lucanix Phase II Clinical Data ...
5 Jun 2006 ... Labor Market Reports · Education & Training ... treating individuals with glioblastoma multiforme or gliosarcoma (brain cancers) in 2007. ...
http://www.biospace.com/news_story.aspx?NewsEntityId=20552...

Intracranial glioblastoma models in preclinical neuro-oncology ...
In this paper, we report histopathological results after a comprehensive .... similar to those of human gliomas: a comparison to 9L gliosarcoma. J Neurooncol.
.... Fine H, Barker F, Market J, Loeffer J. Neoplasms of the central nervous
system. ... International Agency for Research on Cancer; Lyon, France: 2000. pp.
...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2384236/...

Biopure - Scientific Publications
A preliminary report. Eur J Cardiothorac Surg. 1989;3:353-354. ..... The Journal of Applied Research in Veterinary Medicine. 2004;2(1):34-38. ...
http://www.biopure.com/scientific_publications.php...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.